|
ZNF268 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.835700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.378140E-02 |
| Normal-vs-Stage2 |
3.150600E-01 |
| Normal-vs-Stage3 |
3.171800E-01 |
| Normal-vs-Stage4 |
2.395200E-01 |
| Stage1-vs-Stage2 |
8.651200E-01 |
| Stage1-vs-Stage3 |
5.484000E-01 |
| Stage1-vs-Stage4 |
8.028400E-01 |
| Stage2-vs-Stage3 |
7.657000E-01 |
| Stage2-vs-Stage4 |
7.582200E-01 |
| Stage3-vs-Stage4 |
5.142200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.182100E-02 |
| Normal-vs-AfricanAmerican |
1.758210E-01 |
| Normal-vs-Asian |
1.760430E-03 |
| Caucasian-vs-AfricanAmerican |
9.285600E-01 |
| Caucasian-vs-Asian |
2.652800E-01 |
| AfricanAmerican-vs-Asian |
1.922810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.947700E-02 |
| Normal-vs-Female |
6.791400E-01 |
| Male-vs-Female |
1.575610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.416000E-02 |
| Normal-vs-Extreme_Weight |
5.229400E-04 |
| Normal-vs-Obese |
8.209000E-01 |
| Normal-vs-Extreme_Obese |
1.665560E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.527400E-01 |
| Normal_Weight-vs-Obese |
1.632610E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.955200E-01 |
| Extreme_Weight-vs-Obese |
1.562220E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.804600E-01 |
| Obese-vs-Extreme_Obese |
2.996200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.343400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.897000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.921100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.143400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.071800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.372400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.090000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.184800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.289400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.803970E-01 |
| Normal-VS-Type2 PRCC |
4.279300E-03 |
| Normal-VS-KIRP CIMP |
6.562200E-01 |
| Normal-VS-Unclassified PRCC |
8.824400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.049800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.338600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.456000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.057640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.930300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.139200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.335290E-03 |
| Normal-vs-N1 |
3.735400E-01 |
| Normal-vs-N2 |
3.841400E-04 |
| N0-vs-N1 |
3.884900E-03 |
| N0-vs-N2 |
2.359700E-02 |
| N1-vs-N2 |
1.565690E-04 |
|
|
